Compare ADMA Biologics Inc (ADMA) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Novavax Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: ADMA Biologics Inc is the larger of the two by market cap, and Novavax Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | NVAX | |
|---|---|---|
Market Cap | $2.22B | $1.31B |
Sector | Health | Health |
52-Week High | $20.38 | $11.19 |
52-Week Low | $7.60 | $6.22 |
Enterprise Value | $2.29B | $889.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
